Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: J Allergy Clin Immunol. 2008 Oct 25;122(6):1138–1144.e4. doi: 10.1016/j.jaci.2008.09.028

Figure 3.

Figure 3

Product-limit survival function estimates for time to return of inadequate control for children assigned to azithromycin (n=17), montelukast (n=19), and placebo (n=19).